MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer

• প্রধান লেখক: Julius Strauss (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Global Journal of Cancer Therapy - Peertechz Publications, 2017-05-26.
• বিষয়গুলি: Editorial
• অনলাইন ব্যবহার করুন: Connect to this object online.

<p>In the past few years, immunotherapy, particularly immune checkpoint inhibitors, have redefi ned standard of care cancer treatment for numerous malignancies. However, despite the wealth of promising data and great enthusiasm, the vast majority of cancer patients still fail to respond to the...